Arbidol as a broad-spectrum antiviral: An update

Antiviral Research

Volumn 107, Issue 1, 2014, Pages 84-94

  Blaising, Julie ^a   Polyak, Stephen J ^b   Pécheur, Eve Isabelle ^a  

^a CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antiviral therapy; Arbidol; Entry; Fusion; Hepatitis C virus; Influenza

Indexed keywords

ARBIDOL; ANTIVIRUS AGENT; INDOLE DERIVATIVE;

ANTIVIRAL ACTIVITY; CELL FUNCTION; CHIKUNGUNYA ALPHAVIRUS; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG METABOLISM; DRUG PROTEIN BINDING; ENCEPHALITIS; HEMORRHAGIC FEVER; HEPATITIS VIRUS; HUMAN; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REOVIRUS; RESPIRATORY VIRUS; REVIEW; STRUCTURE ACTIVITY RELATION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS RELEASE; VIRUS REPLICATION; VIRUS RESISTANCE; ANIMAL; CHEMISTRY; CHINA; LICENSING; RUSSIAN FEDERATION; TOXICITY;

ANIMALS; ANTIVIRAL AGENTS; CHINA; HUMANS; INDOLES; LICENSURE; PHYSICOCHEMICAL PHENOMENA; RUSSIA;

EID: 84901011755     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.04.006     Document Type: Review

References (95)

1. O.S. Anisimova, L.V. Frolova, V.V. Chistyakov, I.A. Ermachenkov, I.V. Golovanova, S.A. Zotova, A.P. Pleshkova, V.A. Yadrovskaya, and Y.N. Sheinker Study of metabolism of the antiviral drug arbidol by mass spectrometry, thin-layer and high-performance liquid chromatography Pharm. Chem. J. 29 1995 78 82
2. R. Bartenschlager, F. Penin, V. Lohmann, and P. André Assembly of infectious hepatitis C virus particles Trends Microbiol. 19 2011 95 103
3. M.F. Bassendine, D.A. Sheridan, S.H. Bridge, D.J. Felmlee, and R.D. Neely Lipids and HCV Semin. Immunopathol. 35 2013 87 100
4. A.L. Beliaev, E.I. Burtseva, A.N. Slepushkin, and N.A. Beliaeva et al. Arbidole - a new drug for prevention of influenza and acute viral respiratory infections in children [Russian] Vestn. Ross. Akad. Med. Nauk. 8 1996 34 37
5. B.J. Berendsen, R.S. Wegh, M.L. Essers, A.A. Stolker, and S. Weigel Quantitative trace analysis of a broad range of antiviral drugs in poultry muscle using column-switch liquid chromatography coupled to tandem mass spectrometry Anal. Bioanal. Chem. 402 2012 1611 1623
6. E. Bernard, M. Solignat, B. Gay, N. Chazal, S. Higgs, C. Devaux, and L. Briant Endocytosis of chikungunya virus into mammalian cells: role of clathrin and early endosomal compartments PLoS ONE 5 2010 e11479
7. J. Blaising, P.L. Lévy, S.J. Polyak, M. Stanifer, S. Boulant, and E.I. Pécheur Arbidol inhibits viral entry by interfering with clathrin-dependent trafficking Antiviral Res. 100 2013 215 219
8. Y.S. Boriskin, I.A. Leneva, E.I. Pécheur, and S.J. Polyak Arbidol: a broad-spectrum antiviral compound that blocks viral fusion Curr. Med. Chem. 15 2008 997 1005 (Pubitemid 351736402)
9. Y.S. Boriskin, E.I. Pécheur, and S.J. Polyak Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection Virol. J. 3 2006 56
10. S. Boulant, M. Stanifer, C. Kural, D.K. Cureton, R. Massol, M.L. Nibert, and T. Kirchhausen Similar uptake but different trafficking and escape routes of reovirus virions and ISVPs imaged in polarized MDCK cells Mol. Biol. Cell 24 2013 1196 1207
11. V. Brancato, A. Peduto, and S. Wharton et al. Design of inhibitors of influenza virus membrane fusion: synthesis, structure-activity relationship and in vitro antiviral activity of a novel indole series Antiviral Res. 99 2013 125 135
12. B. Brandenburg, L.Y. Lee, M. Lakadamyali, M.J. Rust, X. Zhuang, James M. Hogle, and J.M. Hogle Imaging poliovirus entry in live cells PLoS Biol. 5 7 2007 e183
13. M.J. Brooks, E.I. Burtseva, P.J. Ellery, G.A. Marsh, A.M. Lew, A.N. Slepushkin, S.M. Crowe, and G.A. Tannock Antiviral activity of arbidol, a broad-spectrum drug for use against respiratory viruses, varies according to test conditions J. Med. Virol. 84 2012 170 181
14. M.J. Brooks, J.J. Sasadeusz, and G.A. Tannock Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline? Curr. Opin. Pulmonary Med. 10 2004 197 203 (Pubitemid 38520763)
15. E.I. Burtseva, E.S. Shevchenko, I.A. Leneva, L.N. Merkulova, T.A. Oskerko, O.V. Shliapnikova, A.L. Zaplatnikov, A.M. Shuster, and A.N. Slepushkin Rimantadine and arbidol sensitivity of influenza viruses that caused epidemic morbidity rise in Russia in the 2004-2005 season [Russian] Vopr. Virusol. 52 2007 24 29 (Pubitemid 46724945)
16. E.I. Burtseva, E.S. Shevchenko, N.V. Beliakova, T.A. Oskerko, L.V. Kolobukhina, L.N. Merkulova, R.V. Vartanian, A.G. Prilipov, M. Rotanov, and A.L. Zaplatnikov Monitoring of the sensitivity of epidemic influenza virus strains isolated in Russia to etiotropic chemical agents [Russian] Vopr. Virusol. 54 2009 24 28
17. H. Chai, Y. Zhao, C. Zhao, and P. Gong Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 6-bromo-5-hydroxy-1H-indole-3- carboxylates Bioorg. Med. Chem. 14 2006 911 917 (Pubitemid 43059782)
18. H. Chai, X.X. Liang, L. Li, C.S. Zhao, P. Gong, Z.J. Liang, W.L. Zhu, H.L. Jiang, and C. Luo Identification of novel 5-hydroxy-1H-indole-3- carboxylates with anti-HBV activities based on 3D QSAR studies J. Mol. Model. 17 2011 1831 1840
19. K. Chandran, D.L. Farsetta, and M.L. Nibert Strategy for nonenveloped virus entry: a hydrophobic conformer of the reovirus membrane penetration protein micro 1 mediates membrane disruption J. Virol. 76 2002 9920 9933 (Pubitemid 35006531)
20. C.B. Coyne, L. Shen, J.R. Turner, and J.M. Bergelson Coxsackievirus entry across epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5 Cell Host Microbe 2 2007 181 192 (Pubitemid 47355203)
21. I. Delogu, B. Pastorino, C. Baronti, A. Nougairede, E. Bonnet, and X. de Lamballerie In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant Antiviral Res. 90 2011 99 107
22. Demin, A.V., Martianov, V.A., Shuster, A.M., 2010. Protein kinase C inhibitors exhibiting an anti-inflammatory, anti-allergic and anti-asthma effect. Russian Patent, WO/2010/064958.
23. H.Y. Deng, F. Luo, L.Q. Shi, Q. Zhong, Y.J. Liu, and Z.Q. Yang Efficacy of arbidol on lethal hantaan virus infections in suckling mice and in vitro Acta Pharmacol. Sin. 30 2009 1015 1024
24. P. Deng, D. Zhong, K. Yu, Y. Zhang, T. Wang, and X. Chen Pharmacokinetics, metabolism, and excretion of the antiviral drug arbidol in humans Antimicrob. Agents Chemother. 57 2013 1743 1755
25. V.P. Drinevskǐ, L.V. Osidak, V.K. Natsina, O.I. Afanas'eva, K.K. Mil'kint, G.V. Danini, A.V. Ispolatova, I.E. Koreniako, N.N. Karelina, I.G. Marinich, and V.K. Boldasov Chemotherapeutics for treatment of influenza and other viral respiratory tract infections in children [Russian] Antibiot. Khimioter. 43 1998 29 34 (Pubitemid 128530331)
26. M.Y. Eropkin, M.V. Solovskii, M.Y. Smirnova, T.S. Bryazzhikova, T.M. Gudkova, and N.I. Konovalova Synthesis and biological activity of water-soluble polymer complexes of arbidol Pharm. Chem. J. 43 2009 563 567
27. I.T. Fediakina, I.A. Leneva, S.S. Iamnikova, D.K. L'vov, R.G. Glushkov, and A.M. Shuster Sensitivity of influenza A/H5 viruses isolated from wild birds on the territory of Russia to arbidol in the cultured MDCK cells [Russian] Vopr. Virusol. 50 2005 32 35 (Pubitemid 43074655)
28. I.T. Fediakina, M.I. Shchelkanov, P.G. Deriabin, I.A. Leneva, N.V. Gudova, T.V. Kondrat'eva, and D.K. L'vov Susceptibility of pandemic influenza virus A 2009 H1N1 and highly pathogenic avian influenza virus A H5N1 to antiinfluenza agents in cell culture [Russian] Antibiot. Khimioter. 56 2011 3 9
29. V.M. Gagarinova, G.S. Ignat'eva, L.V. Sinitskaia, A.M. Ivanova, M.A. Rodina, and A.V. Tur'eva The new chemical preparation arbidol: its prophylactic efficacy during influenza epidemics Zh. Mikrobiol. Epidemiol. Immunobiol. 5 1993 40 43 (in Russian) (Pubitemid 24016234)
30. R.Z. Gatich, L.V. Kolobukhina, A.N. Vasil'ev, E.I. Isaeva, E.I. Burtseva, T.G. Orlova, F.V. Voronina, V.D. Kol'tsov, and V.V. Malinovskaia Viferon suppositories in the treatment of influenza in adults Antibiot. Khimioter. 53 2008 13 17 (Russian)
31. R.G. Glushkov Monograph: arbidol. antiviral, immunostimulant, interferon inducer Drugs Future 17 12 1992
32. R.G. Glushkov, T.A. Gus'kova, L.Iu. Krylova, and I.S. Nikolaeva Mechanisms of arbidole's immunomodulating action Vestn. Ross. Akad. Med. Nauk. 3 1999 36 40 (Russian)
33. J. Gouttenoire, F. Penin, and D. Moradpour Hepatitis C virus nonstructural protein 4B: a journey into unexplored territory Rev. Med. Virol. 20 2010 117 129
34. G. Grard, J.N. Fair, D. Lee, and E. Slikas et al. A novel rhabdovirus associated with acute hemorrhagic fever in central Africa PLoS Pathogens 8 9 2012 e1002924
35. P.M. Grimley, I.K. Berezesky, and R.M. Friedman Cytoplasmic structures associated with an arbovirus infection: loci of viral ribonucleic acid synthesis J. Virol. 2 1968 1326 1338
36. S. Haid, T. Pietschmann, and E.I. Pécheur Low pH-dependent hepatitis C virus membrane fusion depends on E2 integrity, target lipid composition, and density of virus particles J. Biol. Chem. 284 2009 17657 17667
37. N.S. Heaton, and G. Randall Dengue virus and autophagy Viruses 3 2011 1332 1341
38. S.B. Iatsyshina, A.N. Minenko, T.E. Kushakova, M.N. Praded, A.V. Kudriavtseva, G.A. Shipulin, V.V. Maleev, and V.I. Pokrovskǐ Pandemic influenza A/H1N1 (sw2009) in Russia: epidemiology, diagnosis, clinical picture, and treatment Ter. Arkh. 82 2010 10 14 (Russian)
39. Y. Inoue, N. Tanaka, Y. Tanaka, S. Inoue, K. Morita, M. Zhuang, T. Hattori, and K. Sugamura Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted J. Virol. 81 2007 8722 8729 (Pubitemid 47242845)
40. H.K. Johannsdottir, R. Mancini, J. Kartenbeck, L. Amato, and A. Helenius Host cell factors and functions involved in vesicular stomatitis virus entry J. Virol. 83 2009 440 453
41. R.A. Khamitov, S.I. Loginova, V.N. Shchukina, S.V. Borisevich, V.A. Maksimov, and A.M. Shuster Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures Vopr. Virusol. 53 2008 9 13 (Russian)
42. A.G. Khan, A. Pickl-Herk, L. Gajdzik, T.C. Marlovits, R. Fuchs, and D. Blaas Human rhinovirus 14 enters rhabdomyosarcoma cells expressing ICAM-1 by a clathrin-, caveolin-, and flotillin-independent pathway J. Virol. 84 2010 3984 3992
43. L.V. Kolobukhina, V.V. Malinovskaia, R.Z. Gatich, L.N. Merkulova, E.I. Burtseva, E.I. Isaeva, O.V. Parshina, T.S. Guseva, T.G. Orlova, and F.V. Voronina Evaluation of the efficacy of wiferon and arbidol in adult influenza Vopr. Virusol. 53 2008 31 33 (Russian) (Pubitemid 351334114)
44. L.V. Kolobukhina, L.N. Merkulova, M.Iu. Shchelkanov, E.I. Burtseva, E.I. Isaeva, N.A. Malyshev, and D.K. L'vov Efficacy of ingavirin in adults with influenza Ter. Arkh. 81 2009 51 54 (Russian)
45. L. Kong, E. Giang, T. Nieusma, and R.U. Kadam et al. Hepatitis C virus E2 envelope glycoprotein core structure Science 342 2013 1090 1094
46. M.A. Krzyzaniak, M.T. Zumstein, J.A. Gerez, P. Picotti, and A. Helenius Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein PLoS Pathogens 9 2013 e1003309
47. P. Kujala, A. Ikaheimonen, N. Ehsani, H. Vihinen, P. Auvinen, and L. Kaariainen Biogenesis of the Semliki Forest virus RNA replication complex J. Virol. 75 2001 3873 3884 (Pubitemid 32246396)
48. G. La Regina, R. Bai, and W.M. Rensen et al. Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors J. Med. Chem. 56 2013 123 149
49. I.A. Leneva, M.V. Sokolova, I.T. Fediakina, M.L. Khristova, N.I. Fadeeva, and T.A. Gus'kova Study of the effect of antiviral drugs on the reproduction of the respiratory syncytial virus by enzyme immunoassay Vopr. Virusol. 47 2002 42 45 (Russian)
50. I.A. Leneva, I.T. Fediakina, T.A. Gus'kova, and R.G. Glushkov Sensitivity of various influenza virus strains to arbidol. Influence of arbidol combination with different antiviral drugs on reproduction of influenza virus A Ter. Arkh. 77 2005 84 88 (Russian) (Pubitemid 41367603)
51. I.A. Leneva, and A.M. Shuster Antiviral etiotropic chemicals: efficacy against influenza A viruses A subtype H5N1 Vopr. Virusol. 51 2006 4 7 (Russian) (Pubitemid 44701583)
52. I.A. Leneva, R.J. Russell, Y.S. Boriskin, and A.J. Hay Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol Antiviral Res. 81 2009 132 140
53. I.A. Leneva, I.T. Fediakina, M.I. Eropkin, N.V. Gudova, A.A. Romanovskaia, D.M. Danilenko, S.M. Vinogradova, A.I. Lepeshkin, and A.M. Shestopalov Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models Vopr. Virusol. 55 2010 19 27 (Russian)
54. J.Y. Leung, M.M. Ng, and J.J. Chu Replication of alphaviruses: a review on the entry process of alphaviruses into cells Adv. Virol. 2011 2011 249640
55. M.Y. Liu, S. Wang, W.F. Yao, H.Z. Wu, S.N. Meng, and M.J. Wei Pharmacokinetic properties and bioequivalence of two formulations of arbidol: an open-label, single-dose, randomized-sequence, two-period crossover study in healthy Chinese male volunteers Clin. Ther. 31 2009 784 792
56. Q. Liu, D.Y. Liu, and Z.Q. Yang Characteristics of human infection with avian influenza viruses and development of new antiviral agents Acta Pharmacol. Sin. 34 2013 1257 1269
57. Q. Liu, H.R. Xiong, L. Lu, Y.Y. Liu, F. Luo, W. Hou, and Z.Q. Yang Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection Acta Pharmacol. Sin. 34 2013 1075 1083
58. X. Liu, X.H. Chen, Y.Y. Zhang, W.T. Liu, and K.S. Bi Determination of arbidol in rat plasma by HPLC-UV using cloud-point extraction J. Chromatogr. B 856 2007 273 277 (Pubitemid 47302925)
59. X. Liu, Y.W. Huang, J. Li, X.B. Li, K.S. Bi, and X.H. Chen Determination of arbidol in human plasma by LC-ESI-MS J. Pharm. Biomed. Anal. 43 2007 371 375 (Pubitemid 44856209)
60. X. Liu, H. Li, K.S. Bi, X.H. Chen, H. Cai, and B.C. Cai Identification of metabolites of arbidol by ultra-high performance liquid chromatography tandem mass spectrometry Yao Xue Xue Bao 47 2012 1521 1526 (Chinese)
61. X. Liu, T. Huang, and J.X. Chen et al. Arbidol exhibits strong inhibition towards UDP-glucuronosyltransferase (UGT) 1A9 and 2B7 Pharmazie 68 2013 945 950
62. S.I. Loginova, S.V. Borisevich, V.A. Maksimov, V.P. Bondarev, and V.E. Nebol'sin Therapeutic efficacy of Ingavirin, a new domestic formulation against influenza A virus (H3N2) Antibiot. Khimioter. 53 2008 27 30 (Russian)
63. S.I. Loginova, S.V. Borisevich, V.A. Maksimov, and V.P. Bondarev Toxicity estimation of unspecific medicinal antiviral agents for prophylaxis and therapy of hazard and especially hazard viral infections Antibiot. Khimioter. 54 2009 11 14 (Russian)
64. P.Y. Lozach, R. Mancini, D. Bitto, R. Meier, L. Oestereich, A. Överby, R. Pettersson, and A. Helenius Entry of bunyaviruses into mammalian cells Cell Host Microbe 7 2010 488 499
65. D.K. L'vov, E.I. Burtseva, L.V. Kolobukhina, E.L. Feodoritova, and E.S. Shevchenko et al. Development of the influenza epidemic in season 2011-2012 in some areas of Russia: results of activity of the influenza etiology and epidemiology center of the ivanovsky institute of virology Vopr. Virusol. 58 2013 15 20 (Russian)
66. C.G. Martinez, R. Guinea, J. Benavente, and L. Carrasco The entry of reovirus into L cells is dependent on vacuolar proton-ATPase activity J. Virol. 70 1996 576 579 (Pubitemid 126508827)
67. J. Mercer, and A. Helenius Virus entry by macropinocytosis Nat. Cell Biol. 11 2009 510 520
68. L. Meertens, C. Bertaux, and T. Dragic Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles J. Virol. 80 2006 11571 11578 (Pubitemid 44788871)
69. R. Metz, P. Muth, M. Ferger, V.G. Kukes, and H. Vergin Sensitive high-performance liquid chromatographic determination of arbidol, a new antiviral compound, in human plasma J. Chromatogr. A 810 1998 63 69 (Pubitemid 28288228)
70. L. Miller, and R. Bergeron Preparative liquid chromatographic isolation of unknown impurities in Arbidol and SI-5 J. Chromatogr. A 658 1994 489 496 (Pubitemid 24079338)
71. D. Moradpour, F. Penin, and C.M. Rice Replication of Hepatitis C virus Nature Rev. Microbiol. 5 2007 453 463 (Pubitemid 46780082)
72. Z.H. Nasser, K. Swaminathan, P. Muller, and K.M. Downard Inhibition of influenza hemagglutinin with the antiviral inhibitor arbidol using a proteomics based approach and mass spectrometry Antiviral Res. 100 2013 399 406
73. N.P. Obrosova-Serova, E.I. Burtseva, I.M. Nevskǐ, R.I. Karmanova, V.I. Nazarov, A.A. Pitkenen, and A.N. Slepushkin The protective action of arbidol during a rise in respiratory diseases in 1990 Vopr. Virusol. 36 1991 380 381 (Russian)
74. E.I. Pécheur, D. Lavillette, F. Alcaras, J. Molle, Y.S. Boriskin, M. Roberts, F.L. Cosset, and S.J. Polyak Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol Biochemistry 46 2007 6050 6059 (Pubitemid 46799166)
75. A.A. Romanovskaia, A.M. Durymanov, and K.A. Sharshov et al. Investigation of susceptibility of influenza viruses A (H1N1), the cause of infection in humans in April-May 2009, to antivirals in MDCK cell culture Antibiot. Khimioter. 54 2009 41 47 (Russian)
76. I. Romero-Brey, A. Merz, A. Chiramel, J.Y. Lee, P. Chlanda, U. Haselman, R. Santarella-Mellwig, A. Habermann, S. Hoppe, S. Kallis, P. Walther, C. Antony, J. Krijnse-Locker, and R. Bartenschlager Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication PLoS Pathogens 8 2012 e1003056
77. G. Sellitto, A. Faruolo, P. de Caprariis, S. Altamura, G. Paonessa, and G. Ciliberto Synthesis and anti-hepatitis C virus activity of novel ethyl 1H-indole-3-carboxylates in vitro Bioorg. Med. Chem. 18 2010 6143 6148
78. T.A. Semenenko, E.P. Sel'kova, T.P. Gotvianskaia, A.D. Gǎdarenko, N.A. Polezhaeva, L.F. Evseeva, and O.G. Nikolaeva Characteristics of the immune status in specific and nonspecific prophylaxis of influenza in elderly persons Zh. Mikrobiol. Epidemiol. Immunobiol. 6 2005 24 28 (Russian)
79. L. Shi, H. Xiong, J. He, H. Deng, Q. Li, Q. Zhong, W. Hou, L. Cheng, H. Xiao, and Z. Yang Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo Arch. Virol. 152 2007 1447 1455 (Pubitemid 47124957)
80. V.I. Shumilov, A.M. Shuster, S.P. Lobastov, V.A. Shevtsov, B.L. Mednikov, S.A. Piiavskǐ, and V.I. Litus Efficacy of arbidol in prophylaxis and treatment of acute respiratory viral infections in servicemen Voen. Med. Zh. 323 51-3 2002 96 (Russian)
81. A.M. Shuster, V.I. Shumilov, V.A. Shevtsov, G.G. Mar'in, and V.N. Kozlov Arbidol used in the prophylaxis of acute respiratory viral infections and their complications in servicemen Voen. Med. Zh. 325 44-5 2004 80 (Russian)
82. M. Solignat, B. Gay, S. Higgs, L. Briant, and C. Devaux Replication cycle of chikungunya: a re-emerging arbovirus Virology 393 2009 183 197
83. J.H. Song, Z.Z. Fang, L.L. Zhu, Y.F. Cao, C.M. Hu, G.B. Ge, and D.W. Zhao Glucuronidation of the broad-spectrum antiviral drug arbidol by UGT isoforms J. Pharm. Pharmacol. 65 2013 521 527
84. Y. Sun, X. He, F. Qiu, X. Zhu, M. Zhao, J. Li-Ling, X. Su, and L. Zhao Pharmacokinetics of single and multiple oral doses of arbidol in healthy Chinese volunteers Int. J. Clin. Pharmacol. Ther. 51 2013 423 432
85. E. Teissier, F. Penin, and E.I. Pécheur Targeting cell entry of enveloped viruses as an antiviral strategy Molecules 16 2010 221 250
86. E. Teissier, G. Zandomeneghi, A. Loquet, D. Lavillette, J.P. Lavergne, R. Montserret, F.L. Cosset, A. Bockmann, B.H. Meier, F. Penin, and E.I. Pécheur Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol PLoS ONE 6 2011 e15874
87. F.A. Trofimov, N.G. Tsyshkova, S.A. Zotova, and A.N. Grinev Synthesis of a new antiviral agent, arbidole Pharm. Chem. J. 27 1993 75 76
88. L. von Kleist, W. Stahlschmidt, and H. Bulut et al. Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition Cell 146 2011 471 484
89. M.Z. Wang, B.Q. Cai, L.Y. Li, J.T. Lin, N. Su, H.X. Yu, H. Gao, J.Z. Zhao, and L. Liu Efficacy and safety of arbidol in treatment of naturally acquired influenza Zhongguo Yi Xue Ke Xue Yuan Xue Bao 26 2004 289 293 (Chinese)
90. M. Wang, B. Shu, W.X. Bai, J. Liu, J. Yao, W.N. Pan, and Y.Y. Pan A 4-week oral toxicity study of an antiviral drug combination consisting of arbidol and acetaminophen in rats Drug Chem. Toxicol. 33 2010 244 253
91. Y. Wang, X. Chen, Q. Li, and D. Zhong Metabolite identification of arbidol in human urine by the study of CID fragmentation pathways using HPLC coupled with ion trap mass spectrometry J. Mass Spectrom. 43 2008 1099 1109
92. F. Wei, J.L. Li, and J.X. Ling et al. Establishment of SYBR green-based qPCR assay for rapid evaluation and quantification for anti-Hantaan virus compounds in vitro and in suckling mice Virus Genes 46 2013 54 62
93. H. Yan, G. Zhong, G. Xu, W. He, and Z. Jing et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus Elife 1 2012 e00049
94. C. Zhao, Y. Zhao, H. Chai, and P. Gong Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 5-hydroxy-1H-indole-3- carboxylates Bioorg. Med. Chem. 14 2006 2552 2558 (Pubitemid 43343642)
95. Q. Zhong, Z. Yang, Y. Liu, H. Deng, H. Xiao, L. Shi, and J. He Antiviral activity of Arbidol against Coxsackie virus B5 in vitro and in vivo Arch. Virol. 154 2009 601 607